Inhibitor Therapeutics, Inc.

10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Regulation FD disclosure Apr 1, 2026 8-K Other events Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Entered a material agreement Feb 24, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Entered a material agreement; Director or officer change Oct 27, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 10-K Fiscal year ended 2023-12-31 Mar 29, 2024 8-K Entered a material agreement; Other events Dec 14, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Director or officer change; Amended charter or bylaws Oct 18, 2023 8-K Director or officer change; Amended charter or bylaws Aug 29, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023 8-K Director or officer change May 31, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 10-K Fiscal year ended 2022-12-31 Mar 31, 2023 8-K Entered a material agreement; Terminated a material agreement; Change in control; Director or officer change Dec 19, 2022 10-Q Quarter ended 2022-09-30 Nov 14, 2022 8-K Other events Sep 15, 2022 10-Q Quarter ended 2022-06-30 Aug 12, 2022 8-K Director or officer change Jun 3, 2022 10-Q Quarter ended 2022-03-31 May 13, 2022 10-K Fiscal year ended 2021-12-31 Mar 30, 2022 8-K Entered a material agreement; Took on a direct financial obligation Jan 18, 2022 10-Q Quarter ended 2021-09-30 Nov 12, 2021 10-Q Quarter ended 2021-06-30 Aug 13, 2021 10-Q Quarter ended 2021-03-31 May 14, 2021 10-K Fiscal year ended 2020-12-31 Mar 26, 2021 8-K Director or officer change Jan 6, 2021 8-K Entered a material agreement; Took on a direct financial obligation Dec 17, 2020 10-Q Quarter ended 2020-09-30 Nov 16, 2020 8-K Director or officer change Sep 23, 2020 10-Q Quarter ended 2020-06-30 Aug 12, 2020 8-K Director or officer change Jun 30, 2020